PMID- 10087948 OWN - NLM STAT- MEDLINE DCOM- 19990407 LR - 20190816 IS - 0165-4608 (Print) IS - 0165-4608 (Linking) VI - 109 IP - 2 DP - 1999 Mar TI - Premature centromere division in patients with multiple endocrine neoplasia type 1. PG - 138-40 AB - Frequency of mitoses with premature centromere division (PCD) was examined in lymphocytes from subjects with multiple endocrine neoplasia type 1 (MEN 1). An increase in PCD after exposure to an alkylating agent was observed in subjects with MEN 1 who carry a heterozygous MEN1 gene mutation but not in normal controls or in affected subjects without the MEN1 gene mutation. These findings support the inclusion of MEN 1 as a chromosome instability syndrome and recognition of PCD as a manifestation of chromosome instability. Furthermore, these results suggest that the MEN1 gene product may function to maintain the integrity of DNA. FAU - Sakurai, A AU - Sakurai A AD - Department of Geriatrics, Endocrinology, and Metabolism, Shinshu University School of Medicine, Matsumoto, Japan. FAU - Katai, M AU - Katai M FAU - Itakura, Y AU - Itakura Y FAU - Ikeo, Y AU - Ikeo Y FAU - Hashizume, K AU - Hashizume K LA - eng PT - Journal Article PL - United States TA - Cancer Genet Cytogenet JT - Cancer genetics and cytogenetics JID - 7909240 RN - 0 (Epoxy Compounds) RN - 0 (MEN1 protein, human) RN - 0 (Neoplasm Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 60OB65YNAB (diepoxybutane) SB - IM MH - Adult MH - Aged MH - Centromere/*genetics MH - Epoxy Compounds/pharmacology MH - Heterozygote MH - Humans MH - Lymphocytes/drug effects MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/*genetics MH - Mutation MH - Neoplasm Proteins/genetics MH - *Proto-Oncogene Proteins MH - Reference Values EDAT- 1999/03/24 00:00 MHDA- 1999/03/24 00:01 CRDT- 1999/03/24 00:00 PHST- 1999/03/24 00:00 [pubmed] PHST- 1999/03/24 00:01 [medline] PHST- 1999/03/24 00:00 [entrez] AID - S0165460898001563 [pii] AID - 10.1016/s0165-4608(98)00156-3 [doi] PST - ppublish SO - Cancer Genet Cytogenet. 1999 Mar;109(2):138-40. doi: 10.1016/s0165-4608(98)00156-3.